Where a unique community
of healthcare entrepreneurs meets capital.
Helsia is a pan-European platform where capital meets entrepreneurship, where experience shapes opportunity, and where a community of proven healthcare leaders and investors are building the healthcare champions of tomorrow.
Discover our approach
About Helsia
We partner with ambitious teams ready to unlock the next level of development, investing €10–50 million of flexible, long-term capital in profitable healthcare companies and helping them scale with purpose.
At the heart of Helsia is a community of 40 accomplished healthcare entrepreneurs whose shared experience, insight, and network make the difference in achieving superior outcomes for patients, companies, employees, management teams, and investors alike.
Building a company is demanding. It takes a clear strategic vision, hard work, the right people, countless decisions — and a good measure of luck. That’s why we work tirelessly at your side: contributing our experience to help you grow and scale; our judgment to navigate complex decisions with clarity and pragmatism; our network to open doors to the right people, ideas, and markets; and our capital to empower you to seize transformative opportunities.
We believe technological innovation — and AI in particular — will continue to reshape healthcare. We already use these tools to source, evaluate, and monitor companies more effectively. Together with our AI partners, we help businesses harness the opportunities created by this transformation — turning disruption into long-term advantage.
Helsia is where entrepreneurial capital meets conviction — to build enduring healthcare leaders across Europe.
Our Community
Behind Helsia stands a unique community of healthcare entrepreneurs, operators, and investors who have built, scaled, and led successful businesses across Europe.
They bring deep sector expertise, trusted relationships, and a belief that partnership — not capital alone — creates lasting impact.
Dr. Thomas Schmidt
Dr. Thomas Schmidt
Steve Rosengarten
Steve Rosengarten
Anne Canel
Anne Canel
Our Portfolio
Helsia invests in profitable healthcare companies with strong fundamentals, proven products, and clear opportunities to scale. Each partnership reflects our philosophy: entrepreneur-led growth, disciplined execution, and long-term value creation.
Type: Specialty Pharma
Location: Monaco
Stake: 100%
(Acquisition completed December 18 2024)
Specialty pharmaceutical laboratory with 50 years of operations and 6 marketing authorizations in gastroenterology, ENT, and oncology. Produces mainly reimbursed and prescription-only drugs (80 % of sales). Helsia acquired from the Founder to launch OTC products, optimize operations and expand into export markets — building a specialty pharma platform for further acquisitions.
Type: Medical Devices Manufacturers
Location: Tovo di San Agata (Sondrio, Italy)
Stake: 43%
(Acquisition completed May 27 2025)
European manufacturer of 2D bags for parenteral nutrition. ISO-8 and ISO-7 certified facility with MDR & FDA 510-K approvals. Partners include large corporation with strong presence in the USA. Helsia exited non-operating shareholders to accelerate international expansion and develop single-use biomanufacturing solutions.
Contact
We’re always open to connecting with healthcare entrepreneurs, operators, and investors who share our vision.
For entrepreneurs:
If you’re building a profitable healthcare company and seeking a long-term partner, we’d love to hear from you.
For investors:
If you’re interested in participating in Helsia’s future opportunities, please reach out to our investment team.